Financial intelligence for Asia's healthcare markets
Remember me:

Singapore: Temasek takes stake in HMI

SGX-listed private healthcare provider Health Management International has announced S$11 million (US$8.1 million) investment from Temasek subsidiary Heliconia Capital Management.

HMI will issue 16.9 million new ordinary shares at S$0.65 per share to Orchid 2 Investments which is managed and controlled by Heliconia. This investment means that Heliconia will hold a 2% stake in the enlarged share capital of the group.

“Heliconia has strong interest in the healthcare sector as it ties in well with regional trends of growing middle class and ageing population. We hope to work closely with HMI to explore more opportunities where we can collaborate,” said Heliconia CEO Derek Lau.

At the same time as the investment HMI announced stellar results for the first quarter of the year. Profits more than doubled to S$13.8 million on revenues that rose 6.9% to S$117.1 million.  

Profits jumped this quarter in the wake of the wake of the consolidation exercise completed at the end of March. As well as strong operational performance, 100% of net income is now attributable to HMI shareholders.

The group registered growth from both foreign and local patients as total patient load increased 5.4%. In addition, average outpatient bill sizes increased 12.2%, while average inpatient bill sizes increased 3.6%. This was mainly attributed to higher revenue intensity and increasingly complex surgeries. During the quarter, the group’s operational bed occupancy remained stable at 61.3%.

In light of the rising demand for healthcare across the region, the group has embarked on expansion initiatives to capture growth opportunities. HMI’s Mahkota hospital plans to increase operational bed capacity from 266 beds to 300 beds during the financial year, while at Regency construction on a new hospital extension block will begin this year.

The new block will more than double existing capacity with additional inpatient beds, clinical services, operating theatres and clinical suites for sale or rental to doctors. The US38 million expected construction cost will be funded by debt and internal cash resources.

When it completes in 2021, Regency will become a 380-bed tertiary hospital, with potential to expand capacity to 500 beds. In the near term, Regency is increasing its operational bed capacity from 166 beds to 200 beds.

“To capture opportunities within medical tourism, we continue to leverage on our 16 patient referral offices across Indonesia, Malaysia and Singapore. We have also taken the initiative to broaden patient referrals to Regency and Mahkota through joint overseas marketing initiatives. Looking ahead, we remain well poised to grow our market share and attract more foreign patients to our hospitals,” said CEO Chin Wei Jia.

Posted on: 14/11/2017 UTC+08:00


Medical diagnostic imaging services provider Capitol Health has said that it expects to return to profitability in the next financial year and has upgraded its outlook for the year.
Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, has said that it is “targeting strong growth in 2018 across all key metrics”.
Malaysian medical glove manufacturer Supermax Group has reported a 42.8% jump in Q1 profits to M$27.9 million (US$6.8 million) on revenues that 16% to M$312 million.
At its annual general meeting, international pathology, imaging and medical centres operator Sonic Healthcare reaffirmed guidance for the year. Chief executive Colin Goldschmidt said that the first quarter of the 2019 financial year confirmed expectations that underlying earnings would grow between 6% and 8% on a constant currency basis.
It has been another great quarter for China Cord Blood Corporation (CCBC), the country’s largest provider of cord blood storage and ancillary services. For the second quarter in a row, profits more than doubled. They came in at US$10.2 million.
New Zealand-based medical device manufacturer Fisher & Paykel Healthcare has reported a steady set of first half figures. Profits were up 4% to NZ$81.3 million (US$55.3 million) on revenues that rose 8% to NZ$458.4 million.
Retirement village operator Arvida has reported a 14.5% slump in profits for the first half of the year to NZ$14.5 million (US$9.9 million). At the same time, revenues were up 27.9% to NZ$60 million.
Medical device manufacturer Microport Scientific Corporation plans to acquire the cardiac rhythm management (CRM) business of London-based medical device manufacturer LivaNova for US$190 million.


The promise of a bottom in Singapore’s office market has caused its ranking as an investment market to soar from next-to-bottom last year to third in this year’s “Emerging Trends in Real Estate Asia Pacific 2018” report, a real estate forecast jointly published by the Urban Land Institute (ULI) and PwC.
Kamal Brar, vice president and general manager of Asia Pacific for data software company Hortonworks, looks at how data analytics can provide effective and affordable healthcare in Singapore.
The latest Sun Life Financial Asia Diabetes Awareness Study reveals an alarming knowledge gap in diabetes. A third of Asian women who are or were pregnant in the past three years are unaware of the risk of developing gestational diabetes in pregnancy, while one in seven births in Asia is currently affected by gestational diabetes.
Gan Kim Yong, Singapore’s minister for health, explains why the private sector needs to get behind the National Electronic Health Record System.
Business leaders in Asia Pacific’s healthcare industry are showing urgency in embracing the fourth industrial revolution, according to the Microsoft Asia Digital Transformation Survey. More than three-quarters of them believe that they need to transform to a digital business to enable future growth and yet only a quarter said that they have a full digital strategy in place today.
An agreement for an additional US$15 million funding from the World Bank will be used to expand health and nutrition coverage in the Lao People's Democratic Republic. It is expected to benefit more than 1 million people across 14 provinces.
Bart Van den Mooter, CEO of the TforG Group, looks at the drivers behind the rapid growth in Asia’s medical tourism market.
The ambitious healthcare agenda under Moon Jae-in's liberal presidency will seek to expand national health insurance reimbursement and limit the burden of excessive medical costs, while overhauling the healthcare system. BMI Research looks at the winners and the losers in the presidential agenda.




Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices